Christopher D Warner (Christopher Warner)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Pluripotent Stem Cells

Saccharomyces Cerevisiae

Top Venues

Drug development research

This page only lists publications with an associated author ORCID identifier.

Publications

Pieter Van den Abbeele, Charlotte N Kunkler, Jonas Poppe, Alexis Rose, Ingmar Aeneas Jan van Hengel, Aurélien Baudot, Christopher D Warner
Serum-Derived Bovine Immunoglobulin Promotes Barrier Integrity and Lowers Inflammation for 24 Human Adults Ex Vivo. Nutrients 16 (11) (2024)
Pieter Van den Abbeele, Charlotte N Kunkler, Jonas Poppe, Alexis Rose, Ingmar Aeneas Jan van Hengel, Aurélien Baudot, Christopher D Warner
Serum-Derived Bovine Immunoglobulin Promotes Barrier Integrity and Lowers Inflammation for 24 Human Adults Ex Vivo. Nutrients 16 (11) (2024)
Pieter Van den Abbeele, Charlotte N Kunkler, Jonas Poppe, Alexis Rose, Ingmar Aeneas Jan van Hengel, Aurélien Baudot, Christopher D Warner
Serum-Derived Bovine Immunoglobulin Promotes Barrier Integrity and Lowers Inflammation for 24 Human Adults Ex Vivo. Nutrients 16 (11) (2024)
Pieter Van den Abbeele, Christopher Detzel, Alexis Rose, Stef Deyaert, Aurélien Baudot, Christopher D Warner
Serum-Derived Bovine Immunoglobulin Stimulates SCFA Production by Specific Microbes in the Ex Vivo SIFR ® Technology. Microorganisms 11 (3) (2023)
Pieter Van den Abbeele, Christopher Detzel, Alexis Rose, Stef Deyaert, Aurélien Baudot, Christopher D Warner
Serum-Derived Bovine Immunoglobulin Stimulates SCFA Production by Specific Microbes in the Ex Vivo SIFR ® Technology. Microorganisms 11 (3) (2023)
Pieter Van den Abbeele, Christopher Detzel, Alexis Rose, Stef Deyaert, Aurélien Baudot, Christopher D Warner
Serum-Derived Bovine Immunoglobulin Stimulates SCFA Production by Specific Microbes in the Ex Vivo SIFR ® Technology. Microorganisms 11 (3) (2023)
Netanya S Utay, David M Asmuth, Shahin Gharakhanian, Moises Contreras, Christopher D Warner, Christopher J Detzel
Potential use of serum-derived bovine immunoglobulin/protein isolate for the management of COVID-19. Drug development research 82 (7) (2021)